Not Yet Recruiting
A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia
NCT06182592
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, High-risk (Secondary) Acute Myeloid Leukemia, +9 more
- Locations
-
- Institute of Hematology and Hospital of Blood Disease, Chinese Academy of Medical Sciences Tianjin, China